Citadel Advisors
IVF

Citadel Advisors’s INVO Fertility Inc IVF Stock Holding History

Citadel Advisors’s Portfolio IVF Stock Details IVF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Hold
0
– -$44 – 15665
2022
Q4 		– Hold
0
– – – 14788
2022
Q2 		– Hold
0
– -$28K – 14307
2022
Q1 		– Hold
0
– – – 13136
2021
Q4 		– Hold
0
– – – 13427

Other funds holding IVF

Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $3.65B AUM 41.88% 1-Year Est. Return

Citadel Advisors's IVF Position: Q1 2026 in Review

Citadel Advisors sold out of INVO Fertility Inc (IVF) in Q1 2026, closing a stake of 4,738 shares — an estimated $17.8K sold.

Citadel Advisors first reported a position in IVF in Q1 2021 and held it in 8 quarters. The position peaked at $98K in Q1 2021. 8 funds tracked by Wall St. Rank hold IVF as of Q1 2026.

  • Citadel Advisors reported no remaining INVO Fertility Inc position as of Q1 2026 after selling out during the quarter.
  • Citadel Advisors sold 4,738 INVO Fertility Inc shares in Q1 2026, an estimated $17.8K.
  • Citadel Advisors first reported a position in INVO Fertility Inc in Q1 2021 and held it in 8 quarters.
  • Citadel Advisors's INVO Fertility Inc position peaked at $98K in Q1 2021.
  • 8 funds tracked by Wall St. Rank held INVO Fertility Inc as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.